Drug‐Induced Subacute Cutaneous Lupus Erythematosus Under Adalimumab in a Child With Polyarticular Juvenile Idiopathic Arthritis: IFN ‐α and TNF ‐α‐Skewed Cytokine Profile | Synapse
April 28, 2026
Drug‐Induced Subacute Cutaneous Lupus Erythematosus Under Adalimumab in a Child With Polyarticular Juvenile Idiopathic Arthritis: IFN ‐α and TNF ‐α‐Skewed Cytokine Profile
Key Points
To describe a case of subacute cutaneous lupus erythematosus induced by adalimumab in a child with juvenile idiopathic arthritis.
Case report involving a child with juvenile idiopathic arthritis receiving adalimumab.
Analyzed cytokine profiles including IFN-alpha and TNF-alpha.
The child developed subacute cutaneous lupus erythematosus while on adalimumab.
Cytokine analysis revealed skewing towards IFN-alpha and TNF-alpha production.
Abstract
The data used or analyzed in this study are available from the corresponding author upon reasonable request.